VF5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ondine Biomedical Inc

Watchlist Manager

Watchlist

Price: 0.136 EUR Market Closed

Market Cap: €37.7m

O	Ondine Biomedical Inc F:VF5	CA
A	Asia Aviation PCL SET:AAV	TH
A	Ahlers AG F:AAH	DE

Profitability Summary

Ondine Biomedical Inc's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

62%

Gross Margin is Increasing

49% > 61%

Negative Operating Margin

-1.133%

Negative 3Y Average Operating Margin

-1.060%

Operating Margin is Increasing

-2.452% > -1.133%

Negative Net Margin

-1.116%

Negative 3Y Average Net Margin

-1.041%

Net Margin is Increasing

-2.326% > -1.116%

Negative Free Cash Flow Margin

-906%

Negative 3Y Average Free Cash Flow Margin

-885%

Free Cash Flow Margin is Increasing

-2.032% > -906%

Negative ROE

-570%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.202%

Declining ROIC

-605% > -1.411%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.